Effectiveness of azacitidine in higher-risk myelodysplastic syndromes

2016-08-01

Leukemia , Volume 30 - Issue 8 p. 1795- 1796

Additional Metadata
Persistent URL	doi.org/10.1038/leu.2016.117, hdl.handle.net/1765/87082
Journal	Leukemia
Organisation	Department of Hematology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Dinmohamed, A., van Norden, Y., van de Loosdrecht, A., & Jongen-Lavrencic, M. (2016). Effectiveness of azacitidine in higher-risk myelodysplastic syndromes. Leukemia, 30(8), 1795–1796. doi:10.1038/leu.2016.117

Publication